The history of presidential health disclosures, from the physician-reporter who's been there for four decades of them: Lawrence K. Altman, MD, of The New York Times.
Pfizer said it was axing its investigational PCSK9 inhibitor bococizumab, citing trial results showing more adverse effects and less long-term efficacy than other drugs in the class.
Unclear what this means for humans, but male mice showed reduced fertility and testicular damage when infected with Zika virus. (Reuters)
CMS said it will delay full enforcement of new Medicare Part D prescriber enrollment requirements for almost 2 years, until Jan. 1, 2019. But it will begin phasing in those requirements in the second half of 2017.
Fireworks shot off during the Hindu festival of Diwali are blamed for a dense particulate-laden smog blanketing New Delhi in India. (U.S. News & World Report)
It's essentially impossible to eliminate residual contamination from robotic surgical instruments, Japanese researchers found. (Infection Control & Hospital Epidemiology)
Vox has a sobering infographic showing how many counties will have just one Obamacare insurer in 2017.
The FDA cleared what manufacturer Neural Analytics called "the first fully portable all-in-one ultrasound system designed for rapid triaging and monitoring of patients with brain disorders."
The legitimacy of marijuana as a medical treatment looks to be tested in a federal court. (Reuters)
Is difficulty accepting delayed gratification responsible for fast-food obsessions? Academics led by an American Cancer Society (!) researcher find evidence in a large survey. (Preventive Medicine)
California is requiring employers of healthcare professionals to develop violence prevention protocols, reports Kaiser Health News.
The powder and bar forms of Soylent, the synthetic nutrient blend sold as a total food substitute, are off the market in the wake of reports that they were making customers ill. (Gizmodo)
Health News Review grades the FDA's news releases at a gentleman's C, mainly because the agency rarely quantifies the benefits of newly approved drugs and devices, and often says little about the quality of evidence on which decisions are made.
Check your knowledge of rare, oddball diseases at Buzzfeed.
H. Steven Moffic, MD, reviews five faddish treatments for psychiatric conditions -- some of which might actually work. (Psychiatric Times)
Is pollution or nature responsible for hexavalent chromium in well water? A new study suggests that industry might not be to blame. (North Carolina Health News)
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.